FDAFDA · Food and drugs·Recall number D-1145-2022
medroxyPROGESTERone Acetate Injectable Suspension, USP, 1 mL Prefilled Syringe, 150 mg/mL, Rx only, Manufactured by Sun Pharmaceutical Industries Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 62756-091-40.
Published June 22, 2022 · Recall initiated: May 6, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of assurance of sterility
What to do
Voluntary: Firm initiated
Recall details
- Brand
- MEDROXYPROGESTERONE ACETATE
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Distributor
- USA Nationwide
- Lot
- Lot #: HAC1951A, Exp 06/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.